QA: GRI Bio Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001824293_2025_GRI_Bio_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001824293, GRI Bio Inc

  xvar xval
0 AssetsCurrent 5,615,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,000
3 remainder_Assets 120,000
4 LiabilitiesCurrent 1,636,000
5 LiabilitiesNoncurrent 71,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,137,089
9 ResearchAndDevelopmentExpense 3,554,068
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,637,844
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,739,000
1 Liabilities 1,707,000
2 Expenses 7,691,157
3 Revenues 0
4 StockholdersEquity 4,032,000
5 NetIncome -9,329,001
6 ComprehensiveNetIncome -9,329,001
7 BaseVar 8,387,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.145
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time